124 related articles for article (PubMed ID: 4853129)
1. Mechanism of interaction of tolbutamide and phenylbutazone in diabetic patients.
Ober KF
Eur J Clin Pharmacol; 1974 Jul; 7(4):291-4. PubMed ID: 4853129
[No Abstract] [Full Text] [Related]
2. Interaction of phenylbutazone and tolbutamide in man.
Szita M; Gachályi B; Tornyossy M; Káldor A
Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):378-80. PubMed ID: 7450929
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical behaviour of phenylbutazone in African diabetics.
Owusu SK; Ocran K
Lancet; 1972 Feb; 1(7747):440-1. PubMed ID: 4110673
[No Abstract] [Full Text] [Related]
4. Determination of phenylbutazone, tolbutamide and metabolites in plasma and urine using chemical ionization mass spectrometry.
Weinkam RJ; Rowland M; Meffin PJ
Biomed Mass Spectrom; 1977 Feb; 4(1):42-7. PubMed ID: 836942
[TBL] [Abstract][Full Text] [Related]
5. [Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out-patients (author's transl)].
Kolenda KD; Grille W; Johnsen K
Med Klin; 1979 Dec; 74(50):1914-22. PubMed ID: 542176
[TBL] [Abstract][Full Text] [Related]
6. [Effect of propranolol on the hypoglycemic action of insulin and tolbutamide in diabetic patients].
Kowalski S; Wolański A
Pol Arch Med Wewn; 1969; 42(1):55-61. PubMed ID: 5767511
[No Abstract] [Full Text] [Related]
7. On the question of an interaction between sulindac and tolbutamide in the control of diabetes.
Ryan JR; Jain AK; McMahon FG; Vargas R
Clin Pharmacol Ther; 1977 Feb; 21(2):231-3. PubMed ID: 837641
[TBL] [Abstract][Full Text] [Related]
8. Influence of tolbutamide on serum glucose level, specific activity of glucose and glucose oxidation in severe diabetes.
Adlung J; Koch CD
Int J Clin Pharmacol; 1974 Sep; 10(2):128-35. PubMed ID: 4448554
[No Abstract] [Full Text] [Related]
9. A study of the possible interaction of indoprofen with hypoglycemic sulfonylureas in diabetic patients.
Pedrazzi F; Bommartini F; Freddo J; Emanueli A
Eur J Rheumatol Inflamm; 1981; 4(1):26-31. PubMed ID: 7042358
[TBL] [Abstract][Full Text] [Related]
10. Interaction of tolbutamide and chloramphenicol in diabetic patients.
Brunová E; Slabochová Z; Platilová H; Pavlik F; Grafnetterová J; Dvorácek K
Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):7-12. PubMed ID: 838527
[TBL] [Abstract][Full Text] [Related]
11. [Recurrent hypoglycemic coma due to abnormal degradation of tolbutamide].
Schulz E; Brinkmann W
Dtsch Med Wochenschr; 1968 Mar; 93(11):485-91. PubMed ID: 5638113
[No Abstract] [Full Text] [Related]
12. Effect of naproxen on glucose metabolism and tolbutamide kinetics and dynamics in maturity onset diabetics.
Whiting B; Williams RL; Lorenzi M; Varady JC; Robins DS
Br J Clin Pharmacol; 1981 Mar; 11(3):295-302. PubMed ID: 7213531
[TBL] [Abstract][Full Text] [Related]
13. [Fluprednisolone, a corticosteroid of slight diabetogenic effect].
Fiegel G; Kukwa D
Arzneimittelforschung; 1970 Jun; 20(6):864-5. PubMed ID: 5468909
[No Abstract] [Full Text] [Related]
14. Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics.
Wajchenberg BL; Nakasone K; Pasternak K
Horm Metab Res; 1970 Jan; 2(1):6-8. PubMed ID: 5520756
[No Abstract] [Full Text] [Related]
15. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
Pond SM; Birkett DJ; Wade DN
Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
[TBL] [Abstract][Full Text] [Related]
16. Borderline diabetics and their response to tolbutamide.
Keen H; Jarrett RJ; Ward JD; Fuller JH
Adv Metab Disord; 1973; 2():Suppl 2:521-31. PubMed ID: 4720382
[No Abstract] [Full Text] [Related]
17. Potentiation of the tolbutamide effect by dicoumarol.
Kristensen M; Hansen JM
Diabetes; 1967 Apr; 16(4):211-4. PubMed ID: 4164590
[No Abstract] [Full Text] [Related]
18. The effect of food on the bioavailability and pharmacodynamics of tolbutamide in diabetic patients.
Antal EJ; Gillespie WR; Phillips JP; Albert KS
Eur J Clin Pharmacol; 1982; 22(5):459-62. PubMed ID: 6749526
[TBL] [Abstract][Full Text] [Related]
19. [Extracellular potassium concentration and fasting blood sugar in diabetes mellitus].
Schwarzbach W
Med Klin; 1970 Jun; 65(24):1161-3. PubMed ID: 5517341
[No Abstract] [Full Text] [Related]
20. [New aspects of therapy with oral antidiabetic agents].
Haslbeck M
Wien Med Wochenschr; 1979 Dec; 199(24):689-95. PubMed ID: 161940
[No Abstract] [Full Text] [Related]
[Next] [New Search]
